disaster health management risk reduction dhmr 1 overview
play

Disaster Health Management & Risk Reduction (DHMR-1) Overview of - PowerPoint PPT Presentation

Disaster Health Management & Risk Reduction (DHMR-1) Overview of Health T echnology Assessment in IRAN Lessons for the EMR region Ali Ak Al Akbari-Sa Sari, M MD, Ph PhD Dean, n, School hool of of Publ ublic Health Teh ehran an U


  1. Disaster Health Management & Risk Reduction (DHMR-1)

  2. Overview of Health T echnology Assessment in IRAN Lessons for the EMR region Ali Ak Al Akbari-Sa Sari, M MD, Ph PhD Dean, n, School hool of of Publ ublic Health Teh ehran an U Univer ersity of M Med edical al Scien ences es th WHS Regi 7 th giona onal Meeting ng 2019 2019 Kish, , I.R I.R. . of Ir Iran; 29 29 to 30 30 April il 2019 2019 akbar ak arisar ari@tums.ac ac.ir Disaster Health Management & Risk Reduction (DHMR-1)

  3.  Development of HTA system in Iran  Challenges of Iran HTA system  Iran health system characteristics  Major characteristics of the region  Main message – implications for HTA in EMR region Disaster Health Management & Risk Reduction (DHMR-1)

  4. Establishment of formal structure for HTA under supervision of Deputy of Treatment (2010), and expansion of this office to provinces (universities of medical sciences) under supervision of Deputy of Treatment

  5.  HTA MSc program in 4 universities  MSc in Health Economics in 10 universities  PhD in Health Economics in 3 universities  PhD in Pharmaco-economics  Short time training programs including workshops on HTA, systematic review, meta-analysis, economic evaluation, …  Other training programs related to HTA e.g. epidemiology, health policy,…

  6.  Following formal establishment of HTA structure in 2010, a specific budget was allocated for HTA by MOH  A proportion of NIHR budget is spent for funding HTA projects  A proportion of medical university research budgets (e.g. for MSc and PhD theses) allocated for HTA  HTA project receive budget also from other resources including insurance organizations, research centers, …

  7.  HTA reflected in Supreme Leader Macro Health Policies … improved decision-making based on sound scientific findings via › development of standards and clinical practice guidelines, health technology assessment, …  HTA emphasized in Health Evolution Plan and other national documents, plans and policies  Mutual agreements with Office of Medical Equipment and NIHR

  8.  Develop localized HTA CoreModel framework › in two categories (medical interventions and diagnostics devices) and three levels (Snapshot, Rapid Review, Full HTA) ›  Stakeholder Analysis in HTA Decision Making Process and their role  Estimate Cost-Effectiveness Threshold Value for IRAN  Estimate Population-Based Preference Weights for Health States for EQ-5D-3L, SF-6D-new version and EQ-5D-5L  Priority-setting of health technology assessment topics  Develop Decision support system for linking HTA to policy

  9.  HTA reports on new technologies (over 120) › Drugs: 20 › Medical devices: 45 › Procedures: 15 › Other: 5 › Rapid reviews: 25 › Ongoing projects: 15  A recent search of databases retrieved 34 economic evaluation papers conducted in Iran and published in peer reviewed medical journals

  10. HTA seem seem s s t o have e very lim it ed im pact on decision m aking …. w hy hy? ?   Wea eak gover ernance: e: › HTA com po ponent s com pl plet e t e but very fragm ent ed › e.g. se several HTA offi ffice ces s in MOH, F FDO, i insu surance ce organizat ions, s, … … › e.g. g. several H HTA fundi ding bo g bodies e. e.g. P PEN I nsulin ex exper erien ence e › Dupl plicat e pr proj e j ect s t s and effort s t s pot ent ia ially lly leading t o g t o di different de t decisions Rules es and reg egulat ions s ver ery lim it ed ed and not ef effec ect ivel ely in place e , and  available regulat ions usually volunt arily  Even en w it h presen esence e of reg egulat ions, s, hea ealt h sy syst st em em gen ener erally unreg egulat ed ed › Deci cisi sions s m ade w it hout u usi sing t t he resu sult s o s of f HTAs s › Use of HTA appr pproved d t echnologi gies for ot h t her pu purpo poses e.g .g. P . PET s scan

  11.  Large e num ber er of t ec echnologies es in place e  Rapid dev evel elopm en ent of new ew t ec echnologies es  Full HTAs s are e t im e e and reso esource e consu sum ing  Policy m akers norm ally in rush not w ait ing for t he HTA result s Lim it ed capacit y, know led edge e and sk skills; s; and not used sed ef efficien ent ly  › e.g. profi fici ciency cy of M f MSc g c gradat es s in HTA? › Capa pacit y t y f for lim it e t ed n d num be ber o of pr proj e j ect s t s › Leadi ding g t o t o s significant de delay in H HTA pr proj e j ect s › Qualit y t y of HTAs and d t h t heir repo port s t s? Lim it ed ed fragm en ent ed ed funds s 

  12. Technical problem s w it h HTA process ess  › Sign gnificant de delay in fundi ding, g, cont ract ing, g, pr propo posal appr pproval, repo port appr pproval, …  HTA TA resu esult s s norm ally n not used sed and im plem em en ent ed ed by policy m aker ers s  Monit oring sy syst st em em s s e. e.g. HI S inef efficien ent (e. e.g. use se of t t ec echnology for o ot her er gr groups ps)  HTA TA not linked ed t o ben enef efit package e and UHC

  13. Even a co com prehensive co com plet e effici cient HTA syst em is not  enough w it hout ot her effici cient syst em s in place ce: e.g. › pa paym ent syst e t em , › regio ionaliz lizat io ion, supply ly lim lim it it , › fa fam ily physi sici cian, refe ferral sy syst st em , › elect ct ronic c reco cords, s, H HI S, › guidelines, pr gu prot o t ocols, st anda dards ds, po policy br briefs, … … › Monit oring and evaluat ions › and ot her co cost st co cont ainm ent and co cost st co cont rol m ech chanism sm s s … … › E.g. i insu surance ce co coverage of P f PEN I nsu sulin › Ordering PEN I nsu sulin by GPs s and sp speci cialist st s s

  14.  Insurance coverage very high (about 95%), but via fragmented insurance organizations  Wide health benefit package includes almost all services  Insufficient and unstable financial resources (e.g. 34 of 40 million insured by IRAN health insurance organization dependent on government budget)  Health system fragmented and unregulated  Payment system dominantly FFS  Family physician not fully implemented, no referral system  HIS not efficient, human resources not enough  Dual practice high  High induced demand and inappropriate use of services  High Inefficiency

  15.  Significant variations and diversities  Transitional health, health system, economy, politics, …  Significant uncertainties  Instability, unrests, wars, conflicts, sanctions  Natural disasters high  Oil dependent economy (not sustainable)  Limited resources, capacity, expertise, …  HTA formal national structure in 2 EMR countries

  16. EMR region situation: implications for HTA?  More important  Urgent need for expansion and improvement  More restrictions  More prioritization e.g. more expensive more costly technologies  Affordability and CE e.g. hepatitis C treatment in IRAN, Pakistan, …

  17. Thank you رﻛﺷﺗ ﺎﺑ Disaster Health Management & Risk Reduction (DHMR-1)

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend